Efficacy of Siddha medicine Vaazhaipoo nei (internal) for Akkaram (Apthous Stomatitis)

Phase II Non-randomized clinical study on Akkaram (Apthous Stomatitis) with the evaluation of Siddha trial drug Vazhai poo nei (internal) in children. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069062

Enrollment

Registered

2024-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K12- Stomatitis and related lesions

Interventions

Intervention1: Vazhai poo nei (internal): Vazhai poo nei 1 -2 grams twice a day for 7 - 14 days. Control Intervention1: Nil: NIl

Eligibility

Inclusion criteria

Inclusion criteria: 1.Ulceration in the oral cavity (up to Grade III of WHO oral mucositis scale) 2.Blisters in the mouth 3.Pallor 4.Fever

Exclusion criteria

Exclusion criteria: 1. Traumatic ulcer 2. Chemical burns 3. Oral ulcer due to cancer 4. Grade IV ulcer (WHO oral mucositis scale) 5. Secondary syphilitic ulcer 6. Herpetic gingivostomatitis

Design outcomes

Primary

Measure	Time frame
Reduction of clinical symptoms (like blisters in mouth, pallor, ulceration) Comparation with WHO oral mucositis scaleTimepoint: 14 days	—

Secondary

Measure	Time frame
It is assessed by comparing the safety parameters before & after treatmentTimepoint: 10 days	—

Countries

India

Contacts

Public ContactDr Abirami R

Government Siddha Medical College Arumbakkam Chennai

mahema.siddha@gmail.com9894325360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026